Kumaresan Sandrasegaran

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Frank H. Miller · 1 shared paper, 2026 · strength 0.36
   • Paper Undifferentiated pancreatic cancer with osteoclast-like giant cells: imaging features. DOI 10.1016/j.crad.2026.107372↗
2. Zhi Ven Fong · 1 shared paper, 2026 · strength 0.30
   • Paper The Neoadjuvant Window: Serial Assessment of Sarcopenia During Treatment for Pancreatic Cancer. DOI 10.1177/00031348261495994↗
3. Nabil Wasif · 1 shared paper, 2026 · strength 0.30
   • Paper The Neoadjuvant Window: Serial Assessment of Sarcopenia During Treatment for Pancreatic Cancer. DOI 10.1177/00031348261495994↗
4. Chee‐Chee Stucky · 1 shared paper, 2026 · strength 0.30
   • Paper The Neoadjuvant Window: Serial Assessment of Sarcopenia During Treatment for Pancreatic Cancer. DOI 10.1177/00031348261495994↗
5. Dillon C. Cheung · 1 shared paper, 2026 · strength 0.30
   • Paper The Neoadjuvant Window: Serial Assessment of Sarcopenia During Treatment for Pancreatic Cancer. DOI 10.1177/00031348261495994↗
6. Mark A. Tann · 2 shared papers, 2013–2019 · strength 0.17
   • Paper CT texture analysis of pancreatic cancer. DOI 10.1007/s00330-018-5662-1↗
   • Paper Use of diffusion-weighted MRI to differentiate chronic pancreatitis from pancreatic cancer. DOI 10.2214/ajr.12.10170↗
7. Thorvardur Ragnar Halfdanarson · 1 shared paper, 2023 · strength 0.14
   • Paper Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-… DOI 10.1016/j.pan.2023.05.008↗
8. Garima Suman · 1 shared paper, 2023 · strength 0.14
   • Paper Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-… DOI 10.1016/j.pan.2023.05.008↗
9. Sovanlal Mukherjee · 1 shared paper, 2023 · strength 0.14
   • Paper Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-… DOI 10.1016/j.pan.2023.05.008↗
10. Candice W. Bolan · 1 shared paper, 2023 · strength 0.14
    • Paper Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-… DOI 10.1016/j.pan.2023.05.008↗
11. Aashna Karbhari · 1 shared paper, 2023 · strength 0.14
    • Paper Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-… DOI 10.1016/j.pan.2023.05.008↗
12. Hala Khasawneh · 1 shared paper, 2023 · strength 0.14
    • Paper Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-… DOI 10.1016/j.pan.2023.05.008↗
13. Mark Joseph Truty · 1 shared paper, 2023 · strength 0.14
    • Paper Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-… DOI 10.1016/j.pan.2023.05.008↗
14. Suresh T. Chari · 1 shared paper, 2023 · strength 0.14
    • Paper Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-… DOI 10.1016/j.pan.2023.05.008↗
15. Shounak Majumder · 1 shared paper, 2023 · strength 0.14
    • Paper Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-… DOI 10.1016/j.pan.2023.05.008↗
16. Ajit Harishkumar Goenka · 1 shared paper, 2023 · strength 0.14
    • Paper Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-… DOI 10.1016/j.pan.2023.05.008↗
17. Safi Shahda · 2 shared papers, 2014–2019 · strength 0.13
    • Paper Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer. DOI 10.1016/j.gie.2018.09.007↗
    • Paper Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in loc… DOI 10.1016/j.ijrobp.2014.02.024↗
18. John M. DeWitt · 2 shared papers, 2014–2019 · strength 0.13
    • Paper Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer. DOI 10.1016/j.gie.2018.09.007↗
    • Paper Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in loc… DOI 10.1016/j.ijrobp.2014.02.024↗
19. Amikar Sehdev · 1 shared paper, 2019 · strength 0.09
    • Paper Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer. DOI 10.1016/j.gie.2018.09.007↗
20. Bert H. O’Neil · 1 shared paper, 2019 · strength 0.09
    • Paper Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer. DOI 10.1016/j.gie.2018.09.007↗
21. Michael Garrett House · 1 shared paper, 2019 · strength 0.09
    • Paper Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer. DOI 10.1016/j.gie.2018.09.007↗
22. Nicholas Joseph Zyromski · 1 shared paper, 2019 · strength 0.09
    • Paper Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer. DOI 10.1016/j.gie.2018.09.007↗
23. Gregory A. Coté · 1 shared paper, 2013 · strength 0.04
    • Paper Use of diffusion-weighted MRI to differentiate chronic pancreatitis from pancreatic cancer. DOI 10.2214/ajr.12.10170↗
24. Romnee S. Clark · 1 shared paper, 2014 · strength 0.03
    • Paper Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in loc… DOI 10.1016/j.ijrobp.2014.02.024↗
25. Higinia Rosa Cardenes · 1 shared paper, 2014 · strength 0.03
    • Paper Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in loc… DOI 10.1016/j.ijrobp.2014.02.024↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.